Challenges of delivering bi-daily general anaesthetic for hyperfractionated accelerated proton beam therapy for high-risk medulloblastoma

EJC Paediatric Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles